Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects. - Herman,GA.; Bergman,A.; Liu,F.; Stevens,C.; Wang,AQ.; Zeng,W.; Chen,L.; Snyder,K.; Hilliard,D.; Tanen,M.; Tanaka,W.; Meehan,AG.; et al. (J Clin Pharmacol, 2006)